Will West (@whlwest) header
Will West (@whlwest) profile picture

Biotech CEO, Dir, Chair; CellCentric, Cyted, F2G, VaxEquity. Morningside Ventures. Prev. JIC, BBSRC, BIA.

Joined February 2011
Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)Photo by Will West (@whlwest)
Closing an incredible era leading @AmericanCancer + @ACSCAN. So proud of what we accomplished in the last 4 yrs and could not ask for a better team. TY Team ACS for this farewell video—I will treasure it! 💙
16
15
5
130
8,940
🚀 Big thanks to @thetimes for featuring Cyted and our Cytoprime 2 project! With NHS backing, we tested 2,000 high-risk patients using EndoSign®, detecting 6 cases of cancer & numerous instances of Barrett’s oesophagus —proving early detection is crucial. tinyurl.com/yrvxs277
1
1
137
We’re 5 years old! Cheers to the incredible Cyted Health team for reaching this milestone - and to everyone who has helped us along the way. Here’s to driving even greater innovation and impact in the years ahead! #EarlyDetection #Healthcare #Innovation
2
2
117
What an experience presenting the first in combination data with Inobrodib Pom and Dex in easily the largest room I’ve ever spoken in! Fantastic to be part of the “into the future” myeloma session to finish off a great #ASH2024. Safe travels home all!
4
1
41
2,550
Cellcentric's inobrodib scores the first multiple myeloma success for p300/CBP inhibition. Here's who else is in play, via @ApexOnco -> oncologypipeline.com/apexonc… $PFE
3
9
1
16
9,534
PRESS RELEASE: cellcentric.com/press-releas… @DrEmmaSearle at #ASH24 shared latest positive inobrodib clinical data in treating multiple myeloma.
2
1
2
742
Will West retweeted
𝐀𝐒𝐇 𝟐𝟎𝟐𝟒: Cambridge, UK based @CellCentric has a unique approach to targeting p300/CBP and thus reducing the activation of oncogenes like IRF4 and MYC in multiple myeloma. #ASH24 Full video: biotechtv.com/post/cellcentr…
2
6
2,088
We will be at #ASH24, presenting latest Phase II data: New Drug in Multiple Myeloma, Dec 9th. Novel MoA, additive to, complementing existing treatments.
1
2
186
We are delighted to collaborate with the American Cancer Society CAN, gaining insights on needs and preferences of people with multiple myeloma. @ACSCAN
1
1
129
The following MPs have been appointed to the Science, Innovation and Technology Committee and our business can now begin. Find out more: committees.parliament.uk/com…
4
29
5
77
17,549
We’ll be at #ASH24, San Diego, Dec 7-10. Sharing latest Phase II clinical data on our pioneering p300/CBP oral inhibitor drug, inobrodib.
1
2
127
As Chair of All Party Parliamentary & Scientific Committee, & former Minister for Science, Research & Innovation I have written to @RachelReevesMP to stress importance of R&D in growing the economy & tackling the big challenges we face... @sciencecampaign georgefreeman.co.uk/news/fre…
4
45
6
158
183,627
In the interests of our patients, we can't continue to fall. The UK has motivated investigators & regulatory timelines have improved but better research infrastructure is essential. Europe falls behind China in playing host to clinical drug trials ft.com/content/3d861acb-8e7d… via @ft
1
2
1
11
1,031
Cambridge surgical robot approved by US regulators thetimes.com/article/3ad20f7…
1
3
39
I really do worry people have forgotten what Covid-19 was like for NHS staff. I went onto ICU wards and saw it myself. I spoke to staff broken by relentless death. @Kevin_Fong testimony @covidinquiryuk needs to be heard:
216
895
71
4,160
289,806
Karen and Debbie are in Rio for #IMS24. Our novel oral drug for R/R multiple myeloma is in Phase II trials. #MMSM #multiplemyeloma
1
3
114
📢Congratulations to @RFitzgerald_lab on her election as an Honorary Fellow of @RAEngNews. She joins 70 leading figures in the field of engineering and technology announced at the Academy's AGM yesterday. 👉raeng.org.uk/new-fellows-202… #RAEngFellows
1
3
25
716
⁦Watching from a distance ⁦@szusmani⁩ at his best at #SOHO24 #mmsm
3
1
20
1,523
We're pleased to share that Dr Stella Peace has been appointed Interim Executive Chair of @InnovateUK from Oct 2024. Currently Innovate UK’s executive director for healthy living & agriculture, she has a strong background in international technology. 🔗 orlo.uk/cvcVw
17
1
65
5,683
Beyond and alongside antibody-based therapies for multiple myeloma, there is a need for novel oral agents, that can be taken in the community.
1
1
133